Maternal and Child Health Symposium

From Clinical Research to Advanced Therapeutics and Precision Medicine

Sidra Medicine Research is proud to launch the first Maternal and Child Health Symposium (MCH). As part of our commitment to improving children and women’s health, this event will bring together eminent researchers, clinicians, nurses, allied health practitioners, trainees, postdocs, students and all members of the community to explore the latest developments and innovations in maternal and child health research.

This symposium will coincide with the International Women's Day.

Common disorders amongst women of reproductive age and pregnancy complications are rapidly increasing worldwide and are associated with a significant health risk for both the mother and her baby. The following incidence rates of some pregnancy complications have been reported in Qatar including gestational diabetes (17.1%), preterm birth (8.5%), pre-eclampsia (3.7%), gestational hypertension (18.4%), stillbirth (6.9%) and low birth weight (8.8%). There is still a knowledge gap in understanding the mechanisms of these complications.

MCH symposium aims to cover the most cutting-edge advances in the field of reproductive health, pregnancy, fetal and post-natal life. Sessions will be centered around high-impact translational and clinical research, advanced therapeutics and precision medicine applications in the field of maternal and child health. With this, we hope to enhance knowledge and improve clinical care practices in Qatar.

CONFERENCE OBJECTIVES:

  • To describe how pregnancy can be a window to future life
  • To list the latest scientific information about clinical and translational research studies in the field of maternal and child health
  • To explain the most advanced therapeutic tools used to improve fertility, to manage pregnancy complications
  • To demonstrate the cutting-edge technologies used to diagnose, manage or treat fetal complications.
  • To compare the bidirectional interaction between mental and reproductive health

TARGET AUDIENCE:

  • Researchers
  • Students
  • Physicians
  • Nurses
  • Pharmacists
  • Allied Health

SYMPOSIUM CHAIRS:

  • Dr. Souhaila Al Khodor - Sidra Medicine, Director - Maternal & Child Health
  • Dr. Annalisa Terranegra - Sidra Medicine, Principal Investigator in Nutritional Genomics and Metabolism

Chairs' Welcome Note
Scientific Organizing, and Planning Committees

SCIENTIFIC:

Abstract Submission
Agenda

PARTNER SOCIETIES

CONTACT US
For additional information or inquiries, please contact one of the organizers below:

  • Dr. Souhaila Al Khodor: salkhodor@sidra.org
  • Dr. Annalisa Terranegra: aterranegra@sidra.org
  • Shaikha Al Abduljabbar: salabduljabbar@sidra.org
  • Maria Brunsman: mbrunsman@sidra.org
 

“This activity is an Accredited Group Learning Activity Category 1 as defined by the Qatar Council for Healthcare Practitioners- Accreditation Department (QCHP-AD) and is approved for a maximum of 20.5 hours.”

“This activity was planned by and for the healthcare team, and learners will receive 20.5 hours Interprofessional Continuing Education (IPCE) credits for learning and change”.

In support of improving patient care, Sidra Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Disclaimer: Qatar Council for Healthcare Practitioners (QCHP) has the full right to revoke CME/CMP credits if they deemed this to be outside your scope of work.